Jay H. Lefkowitch
- Epidemiology top 0.2%
- Hepatology top 0.1%
- Molecular Biology top 5%
- Surgery top 2%
- Oncology top 5%
- Co-authors
- Ira M. JacobsonJules L. DienstagJohn A. PayneCarlo H. TamburroJanice K. AlbrechtRobert P. PerrilloKaren L. LindsayHenry C. Bodenheimer
- Topics
- Liver Disease Diagnosis and Treatment (63 papers)Liver Diseases and Immunity (28 papers)Liver Disease and Transplantation (24 papers)
- Cited by
- HepatologyEpidemiologyPharmacology
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Jay H. Lefkowitch
136 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Epidemiology 4.9k
- Hepatology 4.4k
- Molecular Biology 1.6k
- Surgery 1.4k
- Oncology 797
Countries citing papers authored by Jay H. Lefkowitch
This map shows the geographic impact of Jay H. Lefkowitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay H. Lefkowitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay H. Lefkowitch more than expected).
Fields of papers citing papers by Jay H. Lefkowitch
This network shows the impact of papers produced by Jay H. Lefkowitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay H. Lefkowitch. The network helps show where Jay H. Lefkowitch may publish in the future.
Co-authorship network of co-authors of Jay H. Lefkowitch
This figure shows the co-authorship network connecting the top 25 collaborators of Jay H. Lefkowitch. A scholar is included among the top collaborators of Jay H. Lefkowitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay H. Lefkowitch. Jay H. Lefkowitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 167 | |
| 3 | 53 | |
| 4 | 41 | |
| 5 | 29 | |
| 6 | 22 | |
| 7 | 36 | |
| 8 | 74 | |
| 9 | 45 | |
| 10 | 130 | |
| 11 | 1 | |
| 12 | 191 | |
| 13 | 64 | |
| 14 | 8 | |
| 15 | 6 | |
| 16 | Allograft steatosis is a feature of progressive familial intrahepatic cholestasis, type 1 (FIC1 disease), treated by orthotopic liver transplantation (OLTX). | 5 |
| 17 | 28 | |
| 18 | 16 | |
| 19 | A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis Bbreakdown → | 664 |
| 20 | 5 |
About Jay H. Lefkowitch
Jay H. Lefkowitch is a scholar working on Hepatology, Epidemiology and Transplantation, having authored 141 papers that have together received 8.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (63 papers), Liver Diseases and Immunity (28 papers) and Liver Disease and Transplantation (24 papers). The work is most often cited by research in Hepatology (4.4k citations), Epidemiology (4.9k citations) and Pharmacology (415 citations). Jay H. Lefkowitch has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Ira M. Jacobson, Jules L. Dienstag, John A. Payne, Carlo H. Tamburro, Janice K. Albrecht, Robert P. Perrillo, Karen L. Lindsay, Henry C. Bodenheimer, Alexandra L. Gibas and Carlton Meschievitz. Their work appears in journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.